Viewing Study NCT06263959


Ignite Creation Date: 2025-12-24 @ 2:47 PM
Ignite Modification Date: 2025-12-26 @ 1:13 PM
Study NCT ID: NCT06263959
Status: RECRUITING
Last Update Posted: 2025-03-05
First Post: 2024-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
Sponsor: Fujian Akeylink Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module